Product Information
Composition:
Storage:
Store below 30°CUnique Identification Code:
(01)08901148251441Manufacturing License Number:
MNB/05/107
About the Product
Mintop 2% Solution belongs to the class of ‘vasodilators’ used to treat alopecia (hair loss). Mintop 2% Solution stimulates hair growth and slows down the process of balding. Alopecia is the thinning or loss of hair on the scalp or any part of the body.
Mintop 2% Solution belongs to the class of ‘vasodilators’ used to treat alopecia (hair loss). Mintop 2% Solution stimulates hair growth and slows down the process of balding. Alopecia is the thinning or loss of hair on the scalp or any part of the body.
Mintop 2% Solution belongs to the class of ‘vasodilators’ used to treat alopecia (hair loss). Mintop 2% Solution stimulates hair growth and slows down the process of balding. Alopecia is the thinning or loss of hair on the scalp or any part of the body.
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
Doctor’s voice
How to manage your health
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction. CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
- CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
- CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
Common Patients Concerns
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
How long does it take for this medicine to take effect? How long does it take for this medicine to take effect?
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction. CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction.
Suspendisse faucibus nunc et pellentesque
CIDMUS is indicated to reduce the risk of cardiovascular death
How long does it take for this medicine to take effect?
CIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fractionCIDMUS is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure with a reduced ejection fraction
1.
2.
3.
4.
5.
6.
7.jdjdjd
8.
